Stability testing of peptides, explained

Stability testing is how the storage recommendations on a peptide label are established: not by rule of thumb but by holding samples under defined conditions and measuring what changes. Researchers rarely need to run a formal stability study, but understanding how one works helps interpret storage guidance, decide how long a stock can be trusted, and design an in-house check when a project depends on it. This note explains the structure of a peptide stability study, what is measured, and how the results translate to the bench. All Alphex products are for laboratory and in-vitro research only.

The structure of a stability study

1. Conditions. Samples of one batch are stored at several temperatures and humidities: for example -20 C, 2-8 C, 25 C/60% RH, and an accelerated condition such as 40 C/75% RH. Solutions are studied separately from lyophilised powder, and light exposure may be a further arm.
2. Time points. Samples are pulled at intervals: 0, 1, 3, 6, 12, 24 months for long-term conditions; 0, 1, 2, 3, 6 months for accelerated.
3. Measurements. At each pull: HPLC purity and impurity profile against the time-zero chromatogram, mass spectrometry if new peaks appear, appearance, water content if relevant, and for solutions pH and clarity.
4. Criteria. The material is stable at a condition for as long as it stays within specification, typically purity not falling more than a defined amount and no single impurity exceeding a limit.

The accelerated arm is used to predict long-term behaviour and to identify which degradation route dominates: a peptide that loses purity fast at 40 C with a growing +16 Da peak has an oxidation problem; one with a growing +1 Da earlier peak has a deamidation problem. See deamidation and oxidation.

What the results typically show

• Lyophilised short peptides at -20 C: no measurable change over 24 months or more.
• Lyophilised at 25 C: usually stable for months, then slow decline, faster for sensitive sequences.
• Solutions at 2-8 C: measurable decline within weeks to months depending on the sequence and pH.
• Solutions at 25 C: days to weeks.

These are the studies behind the general guidance in long-term storage and how long reconstituted peptides last.

Running an in-house check

A laboratory that will use one peptide heavily over a long project can run a cut-down version: reconstitute a vial, aliquot, store aliquots under the conditions actually used (fridge, freezer, bench), and pull one at each of a few time points for HPLC against the day-zero run. Half a day of instrument time answers "how long can I trust this stock in my conditions" definitively, and the answer is often more generous than the conservative rules, or occasionally less. Record the method so it can be repeated on the next batch. See how often peptides should be retested.

Reading stability claims from suppliers

"Stable for 2 years" on a label without a stated condition is meaningless. Ask: at what temperature, powder or solution, and on what evidence. Manufacturer data for common research peptides exist and a supplier should be able to point to them or to their own retest results. Alphex's storage guidance for each compound (on the specification table and in the storage note) is drawn from manufacturer stability data and independent retesting of ageing stock, and is deliberately conservative.

Frequently asked questions

Does Alphex publish stability data?

The COA reflects the batch at test; retest results are added to the certificate when a batch is retested. Compound-level guidance is on the product pages. Ask via the contact form for anything more specific.

Is accelerated data reliable for peptides?

Useful for identifying degradation routes and ranking conditions; less reliable for predicting exact shelf life, because some routes (aggregation, for example) do not follow simple temperature scaling.

Sources and further reading

• ICH Quality Guidelines (Q1A stability, Q3A/Q3B impurities, Q6 specifications): the reference framework for purity, impurity and stability testing

Alphex research peptides are supplied for laboratory and in-vitro research by qualified researchers only. They are not authorised for human or veterinary use.

Research use only. Alphex products are supplied exclusively for laboratory and in-vitro research by qualified researchers. They are not authorised for human or veterinary use, and nothing in this note is advice on any such use.

Published 20 March 2026, last reviewed 16 August 2026. Alphex reviews research notes when the testing method, the catalogue or UK guidance changes.

Alphex Research Team

Alphex Limited, UK research peptide supplier

The Alphex research team writes and maintains these notes for UK laboratories buying research peptides. Every batch Alphex lists is verified by reverse-phase HPLC with a batch-matched Certificate of Analysis. Content covers laboratory and in-vitro research only.